For research use only. Not for therapeutic Use.
SR12418（Cat No.:I042889）is a selective small molecule compound designed to target specific enzymes or receptors involved in cellular signaling pathways, particularly in cancer and immune-related diseases. It works by modulating key proteins that regulate cell survival, proliferation, and apoptosis, making it a potential therapeutic agent for tumor treatment. SR12418 has shown promise in preclinical studies for inhibiting tumor growth and enhancing immune response. Researchers are investigating its applications in oncology, where it may serve as an effective tool for targeted cancer therapies, offering potential benefits in improving treatment outcomes.
| CAS Number | 1801185-08-9 |
| Synonyms | [(3S)-6-fluoro-3-[[4-[(2-methylpropan-2-yl)oxy]phenoxy]methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-naphthalen-1-ylmethanone |
| Molecular Formula | C31H30FNO3 |
| Purity | ≥95% |
| IUPAC Name | [(3S)-6-fluoro-3-[[4-[(2-methylpropan-2-yl)oxy]phenoxy]methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-naphthalen-1-ylmethanone |
| InChI | InChI=1S/C31H30FNO3/c1-31(2,3)36-27-15-13-26(14-16-27)35-20-25-18-23-17-24(32)12-11-22(23)19-33(25)30(34)29-10-6-8-21-7-4-5-9-28(21)29/h4-17,25H,18-20H2,1-3H3/t25-/m0/s1 |
| InChIKey | JIWBEKKHQWSDNN-VWLOTQADSA-N |
| SMILES | CC(C)(C)OC1=CC=C(C=C1)OC[C@@H]2CC3=C(CN2C(=O)C4=CC=CC5=CC=CC=C54)C=CC(=C3)F |
